AlphAIalphai — Financial news for AI agents
Stock TitanAPR 102 min read$CLOVNeutralLow

Clover Health (CLOV) finance VP reports 311,169 unvested RSUs in Form 3

Joseph Frank Oldakowski, VP of Finance and Controller at Clover Health Investments, Corp. (CLOV), has filed an initial ownership report (Form 3) disclosing beneficial ownership of 311,169 shares of Class A common stock. These shares are part of unvested time-based restricted stock units granted on June 16, 2025, and December 19, 2025, and represent equity-based compensation rather than open-market transactions. The filing clarifies that this is an initial statement of ownership, not a buy or sell transaction.

AI DeskApril 10, 2026
AI analysis
Actionability
Low
Sentiment · $CLOV
Neutral
Timing
low
Market alignment
aligned with neutral market sentiment
Why this matters for $CLOV

The disclosure of 311,169 unvested RSUs by Clover Health's VP of Finance is an initial ownership statement, not a trading activity. It signals potential future insider selling but does not immediately impact stock price.

Relevance context

The filing pertains to Clover Health (CLOV), indicating insider ownership of unvested RSUs.

Price-impact prediction

Minimal immediate impact; potential for future price movement if vesting leads to insider selling.

Background

Clover Health's VP of Finance filed an initial ownership report, revealing unvested RSUs.

Why it matters

This disclosure is standard and does not imply immediate trading activity; market impact is expected to be minimal.

Market relevance

The news is primarily relevant for investors monitoring insider ownership and potential future trading activity in CLOV.

Market effects

Sector

Limited; the news pertains to insider ownership disclosure and does not affect sector fundamentals.

Regional

None; specific to company insider activity.

Global

Negligible; localized company-level event.

Alternative perspectives

Contrarian view

Some traders may interpret insider ownership disclosures as a sign of insider confidence, potentially supporting the stock.

Overlooked factors

The actual impact depends on subsequent insider trading; this filing alone does not indicate trading intentions.

Key entities

  • Person
    Joseph Frank Oldakowski

    VP of Finance and Controller at Clover Health Investments.

  • Company
    Clover Health Investments

    Healthcare technology company.

Read at source← All news

Related articles

JUN 4
$CLOVMed

Why Clover Health (CLOV) Stock Is Up Today

Clover Health (CLOV) shares rose 9.3% in the afternoon after Canaccord Genuity raised its price target to $4.20 from $3.20 and kept a Buy rating, citing progress in its 2026 managed-care thesis. The article notes CLOV’s high volatility and recent strong results, including Q1 2026 EPS of $0.05 and revenue of $749.2 million.

markets.financialcontent.com4 min
MAY 29
$INFQMed

11 Stocks Racking Up Monstrous Gains

On Thursday, 11 stocks with market caps above $2B and at least 5M shares traded posted double-digit gains, helping all three US indices finish higher (Nasdaq +0.91%, S&P 500 +0.58%, Dow +0.05%). Infleqtion rose 14.94% on plans to triple UK capacity; Best Buy gained 15.80% after Q1 fiscal 2027 results and guidance; Clover Health jumped 16.43% after a court order tied to 2026 star ratings; Agilent rose on Q2 earnings and raised outlook; Dollar Tree climbed 17.87% on Q1 revenue and sales growth.

insidermonkey.com6 min
MAY 19
$CLOVLow

RSU vesting leads Clover Health (CLOV) interim CFO to tax share withholding

Clover Health's interim CFO, Joseph Clay, had 16,942 Class A shares automatically withheld at $3.47 per share on May 16, 2026, to cover tax obligations from RSU vesting. This tax withholding represents 6.25% of his original RSU grant from February 2024, with remaining RSUs vesting quarterly until February 2028, subject to continued service. Following this transaction, Clay directly holds 1,217,584 Class A shares.

Stock Titan2 min
APR 3
$CLOVMed

Clover Health (CLOV) awards 382,522 RSUs to Chief Legal Officer

Clover Health Investments (CLOV) has granted its Chief Legal Officer, Karen Soares, 382,522 Restricted Stock Units (RSUs) of Class A common stock. These RSUs were awarded at no cash cost, increasing her direct ownership to 1,582,583 shares. The vesting schedule dictates that 25% will vest on April 1, 2027, with the remainder vesting in quarterly installments until April 1, 2030, contingent on her continued employment.

Stock Titan2 min